Kateryna Volodymyrivna Nemaltsova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Kateryna Volodymyrivna Nemaltsova has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Olena Mykolayivna Sukhina
State Organization «Grigoriev Institute for Medical Radiology and Oncology of the National Academy of Medical Sciences of Ukraine», Kharkiv, Ukraine
9 shared publications - Vladyslav Sukhin
Grigoriev Institute for Medical Radiology and Oncology NAMS Ukraine, Kharkiv, Ukraine
9 shared publications - L. Ya. Vasylyev6 shared publications
- Ye.B. Radzishevska
Kharkiv National Medical University, Kharkiv, Ukraine
6 shared publications - H.I. Hranovska3 shared publications
Є.б. Радзішевська
State Organization «Grigoriev Institute for Medical Radiology and Oncology of the National Academy of Medical Sciences of Ukraine», Kharkiv, Ukraine; Kharkiv National Medical University of the Ministry of Health of Ukraine, Kharkiv, Ukraine
3 shared publications
Latest Publications
- Open Access
- 30 September 2026
- Published by Institute for Medical Radiology and Oncology of NAMS of Ukraine in Український радіологічний та онкологічний журнал
- Vol. 34 (3)
Immunotherapy – a new stage in the treatment of locally advanced cervical cancer
Background. Cervical cancer ranks the fifth place in cancer incidence structure among women in the world and second place in the structure of cancer incidence among women of reproductive age in Ukraine. Despite screening programs, about 25% of cases in Ukraine are diagnosed at advanced (III–IV) stage, which critically reduces five-year survival rate (from 91% in early stages to 17–19% in case of metastatic disease ) in the whole population. Purpose – to analyze the evolution of treatment methods for locally advanced cervical cancer, based on large-scale clinical trials and to highlight the effectiveness of integrating immunotherapy into modern treatment guidelines for LACC patients. Materials and Methods. There was conducted a systematic review of full-text publications, cited by PubMed and Europe PMC databases. Scientific analysis was supplemented with a description of our own clinical observation of a patient with a locally advanced cervical cancer, who received treatment with immunotherapy. Results. The transformation of treatment standards from radiation therapy alone to modern concomitant chemoradiotherapy was studied. The key phase III clinical trials, that defined modern standards for cervical cancer therapy were analyzed. It was established that GOG 120 study confirmed as the «gold standard» the combined chemoradiotherapy based on cisplatin. It was proven that the addition of bevacizumab (GOG 240) and the introduction of pembrolizumab immunotherapy (KEYNOTE-826) has significantly improved overall survival rates in metastatic forms. Particular attention is paid to the results of GOG 3047 study, which demonstrated that the addition of pembrolizumab to standard therapy reduces the risk of death by 33% in patients with locally advanced disease. The effectiveness of antibody-drug conjugates (Tizotumab vedotin) is also highlighted, which has opened up new opportunities for the treatment of recurrent cervical cancer. Conclusions. Results from clinical trials demonstrate that combining of anti-PD-1 therapy (pembrolizumab) with chemoradiotherapy in high-risk locally advanced cervical cancer patients provides statistically and clinically significant improvements in progression-free and overall survival. This treatment strategy represents a promising new standard of care for the above-mentioned group of patients.
- 30 September 2026
- Published by Institute for Medical Radiology and Oncology of NAMS of Ukraine in Український радіологічний та онкологічний журнал
- Vol. 34 (3)
Open AccessImmunotherapy – a new stage in the treatment of locally advanced cervical cancer
Background. Cervical cancer ranks the fifth place in cancer incidence structure among women in the world and second place in the structure of cancer incidence among women of reproductive age in Ukraine. Despite screening programs, about 25% of cases in Ukraine are diagnosed at advanced (III–IV) stage, which critically reduces five-year survival rate (from 91% in early stages to 17–19% in case of metastatic disease ) in the whole population. Purpose – to analyze the evolution of treatment methods for locally advanced cervical cancer, based on large-scale clinical trials and to highlight the effectiveness of integrating immunotherapy into modern treatment guidelines for LACC patients. Materials and Methods. There was conducted a systematic review of full-text publications, cited by PubMed and Europe PMC databases. Scientific analysis was supplemented with a description of our own clinical observation of a patient with a locally advanced cervical cancer, who received treatment with immunotherapy. Results. The transformation of treatment standards from radiation therapy alone to modern concomitant chemoradiotherapy was studied. The key phase III clinical trials, that defined modern standards for cervical cancer therapy were analyzed. It was established that GOG 120 study confirmed as the «gold standard» the combined chemoradiotherapy based on cisplatin. It was proven that the addition of bevacizumab (GOG 240) and the introduction of pembrolizumab immunotherapy (KEYNOTE-826) has significantly improved overall survival rates in metastatic forms. Particular attention is paid to the results of GOG 3047 study, which demonstrated that the addition of pembrolizumab to standard therapy reduces the risk of death by 33% in patients with locally advanced disease. The effectiveness of antibody-drug conjugates (Tizotumab vedotin) is also highlighted, which has opened up new opportunities for the treatment of recurrent cervical cancer. Conclusions. Results from clinical trials demonstrate that combining of anti-PD-1 therapy (pembrolizumab) with chemoradiotherapy in high-risk locally advanced cervical cancer patients provides statistically and clinically significant improvements in progression-free and overall survival. This treatment strategy represents a promising new standard of care for the above-mentioned group of patients.
- Open Access
- 31 March 2026
- Published by Institute for Medical Radiology and Oncology of NAMS of Ukraine in Український радіологічний та онкологічний журнал
- Vol. 34 (1)
Radiation therapy for non-tumor diseases: current state of the issue
Background. Non-oncological radiotherapy is not very common among radiotherapy centers and is often unknown to other specialists. The advantages of this method are ease of use and the possibility of using it in outpatient settings, which ensures its high cost-effectiveness. The use of radiotherapy in patients with non-tumor diseases often makes it possible not only to reduce the dose of anti-inflammatory and analgesic drugs, but also to improve the quality of life in general. For the most part, the underestimation of radiotherapy for benign conditions is associated with insufficient awareness of doctors about the possibilities and results of treatment and a clear exaggeration of the danger of developing possible radiation damage, adverse long-term genetic and somatic consequences when using it, as well as the introduction into healthcare practice of numerous effective medications, although not always safe for the patientʼs body in terms of the development of side effects. Purpose – analysis and synthesis of current data on radiotherapy for non-tumor diseases with the popularization of information among the medical community. Materials and Methods. In-depth analysis of full-text scientific publications available in the modern information space over the last 10 years. Results. The authors conducted a thorough analysis of the modern literature on radiation therapy for non-oncological conditions and diseases. Unfounded distrust of radiation therapy for non-neoplastic diseases led to a misunderstanding of the importance of this method, the benefits of which are much higher than the possibility of harmful effects calculated using hypotheses and extrapolations. The effectiveness of radiation therapy for non-neoplastic diseases is explained by the anti-inflammatory, analgesic, desensitizing, antispastic and antisecretory effects of ionizing radiation. Typically, a single focal dose (SFD) is 0.3–0.5–0.7 Gy, the total focal dose (TFD) is 4–6 Gy with an irradiation rhythm of 3 times a week (every other day). At the initial stage of the inflammatory process, irradiation can lead to its cessation, which is manifested in a decrease in pain, the disappearance of edema and tissue infiltration. Some patients may experience an initial short-term exacerbation of the inflammatory reaction. Conclusions. It is undisputed that the main area of application of radiotherapy in the near future will remain oncology. However, the picture of the use of ionizing radiation in medicine would be far from complete if radiotherapy of non-tumor diseases were left without due attention. Therefore, non-oncological radiotherapy requires further research and use in clinical practice.
- 31 March 2026
- Published by Institute for Medical Radiology and Oncology of NAMS of Ukraine in Український радіологічний та онкологічний журнал
- Vol. 34 (1)
Open AccessRadiation therapy for non-tumor diseases: current state of the issue
Background. Non-oncological radiotherapy is not very common among radiotherapy centers and is often unknown to other specialists. The advantages of this method are ease of use and the possibility of using it in outpatient settings, which ensures its high cost-effectiveness. The use of radiotherapy in patients with non-tumor diseases often makes it possible not only to reduce the dose of anti-inflammatory and analgesic drugs, but also to improve the quality of life in general. For the most part, the underestimation of radiotherapy for benign conditions is associated with insufficient awareness of doctors about the possibilities and results of treatment and a clear exaggeration of the danger of developing possible radiation damage, adverse long-term genetic and somatic consequences when using it, as well as the introduction into healthcare practice of numerous effective medications, although not always safe for the patientʼs body in terms of the development of side effects. Purpose – analysis and synthesis of current data on radiotherapy for non-tumor diseases with the popularization of information among the medical community. Materials and Methods. In-depth analysis of full-text scientific publications available in the modern information space over the last 10 years. Results. The authors conducted a thorough analysis of the modern literature on radiation therapy for non-oncological conditions and diseases. Unfounded distrust of radiation therapy for non-neoplastic diseases led to a misunderstanding of the importance of this method, the benefits of which are much higher than the possibility of harmful effects calculated using hypotheses and extrapolations. The effectiveness of radiation therapy for non-neoplastic diseases is explained by the anti-inflammatory, analgesic, desensitizing, antispastic and antisecretory effects of ionizing radiation. Typically, a single focal dose (SFD) is 0.3–0.5–0.7 Gy, the total focal dose (TFD) is 4–6 Gy with an irradiation rhythm of 3 times a week (every other day). At the initial stage of the inflammatory process, irradiation can lead to its cessation, which is manifested in a decrease in pain, the disappearance of edema and tissue infiltration. Some patients may experience an initial short-term exacerbation of the inflammatory reaction. Conclusions. It is undisputed that the main area of application of radiotherapy in the near future will remain oncology. However, the picture of the use of ionizing radiation in medicine would be far from complete if radiotherapy of non-tumor diseases were left without due attention. Therefore, non-oncological radiotherapy requires further research and use in clinical practice.
- Open Access
- 30 June 2025
- Published by Institute for Medical Radiology and Oncology of NAMS of Ukraine in Український радіологічний та онкологічний журнал
- Vol. 33 (2) , 248-269
Analysis of the current state of the problem of treating early stages of cervical cancer as a basis for creating a research database
Background. The stress factor against the backdrop of active military actions leads to a rapid increase in oncological pathologies, particularly the incidence of cervical cancer. Delayed seeking of medical assistance worsens the prognosis for recurrence-free survival, especially among young women. The application of modern information technologies to large sets of follow-up data from patients with early-stage cervical cancer enables the identification of correlations between oncological treatment outcomes (recurrence, metastases, secondary cancers) and treatment toxicity with patientsʼ clinical and biological characteristics and treatment specifics with minimal human resource involvement. The identified correlations will allow the development of proposals to adjust antitumor therapy amid the forced intensification of the treatment process, ensuring individualized patient support during the post-war recovery of the country. Purpose – To conduct a scientific analysis of existing approaches to the treatment of early-stage cervical cancer with the aim of creating a necessary foundation for the development of an infological model of a scientific research database for the further justification of individualized chemoradiotherapy. Materials and Methods. In-depth analysis of full-text scientific publications available in the modern information space over the past decade. Results. The authors conducted a thorough analysis of contemporary literature on assessing the effectiveness of treatment for patients with early-stage cervical cancer and identified a set of potential prognostic factors related to the disease, the patient, and the treatment. Disease-related factors include the histological type of the tumor, tumor size, stage, parametrial involvement, prognostic nutritional index, lymphovascular space invasion, and lymph node status. Patient-related factors include overall treatment duration, nutritional status, clinical characteristics, comorbidities, and age. Treatment-related factors encompass additional chemotherapy, external beam radiation therapy, brachytherapy, and the evaluated quality of radiation therapy delivered. The analysis revealed which parameters, factors, and critical nuances of the disease and treatment strategy must be considered to ensure successful treatment outcomes and to predict patient survival. Conclusions. The analysis of contemporary scientific information sources has made it possible to systematize current advancements in the field of early-stage cervical cancer treatment and to define a set of parameters for the infological model of a research database. This serves as a foundation for conducting a scientific study aimed at substantiating a program for the individualization of chemoradiotherapy and post-treatment monitoring of patients.
- 30 June 2025
- Published by Institute for Medical Radiology and Oncology of NAMS of Ukraine in Український радіологічний та онкологічний журнал
- Vol. 33 (2) , 248-269
Open AccessAnalysis of the current state of the problem of treating early stages of cervical cancer as a basis for creating a research database
Background. The stress factor against the backdrop of active military actions leads to a rapid increase in oncological pathologies, particularly the incidence of cervical cancer. Delayed seeking of medical assistance worsens the prognosis for recurrence-free survival, especially among young women. The application of modern information technologies to large sets of follow-up data from patients with early-stage cervical cancer enables the identification of correlations between oncological treatment outcomes (recurrence, metastases, secondary cancers) and treatment toxicity with patientsʼ clinical and biological characteristics and treatment specifics with minimal human resource involvement. The identified correlations will allow the development of proposals to adjust antitumor therapy amid the forced intensification of the treatment process, ensuring individualized patient support during the post-war recovery of the country. Purpose – To conduct a scientific analysis of existing approaches to the treatment of early-stage cervical cancer with the aim of creating a necessary foundation for the development of an infological model of a scientific research database for the further justification of individualized chemoradiotherapy. Materials and Methods. In-depth analysis of full-text scientific publications available in the modern information space over the past decade. Results. The authors conducted a thorough analysis of contemporary literature on assessing the effectiveness of treatment for patients with early-stage cervical cancer and identified a set of potential prognostic factors related to the disease, the patient, and the treatment. Disease-related factors include the histological type of the tumor, tumor size, stage, parametrial involvement, prognostic nutritional index, lymphovascular space invasion, and lymph node status. Patient-related factors include overall treatment duration, nutritional status, clinical characteristics, comorbidities, and age. Treatment-related factors encompass additional chemotherapy, external beam radiation therapy, brachytherapy, and the evaluated quality of radiation therapy delivered. The analysis revealed which parameters, factors, and critical nuances of the disease and treatment strategy must be considered to ensure successful treatment outcomes and to predict patient survival. Conclusions. The analysis of contemporary scientific information sources has made it possible to systematize current advancements in the field of early-stage cervical cancer treatment and to define a set of parameters for the infological model of a research database. This serves as a foundation for conducting a scientific study aimed at substantiating a program for the individualization of chemoradiotherapy and post-treatment monitoring of patients.
- Open Access
- 3 December 2024
- Published by Institute for Medical Radiology and Oncology of NAMS of Ukraine in Український радіологічний та онкологічний журнал
- Vol. 32 (4) , 478-490
Determination of risk factors for the occurrence of recurrences, metastases, and somatic complications after treatment of locally advanced cervical cancer using modern information technologies
Background. According to current data, the average incidence rate of cervical cancer is 9.0 cases per 100,000 people in developed countries and 17.8 cases per 100,000 people in developing countries. At the same time, the percentage of advanced stages (III–IV) of the disease remains high. Continuous improvement of radiation therapy methods has made it possible to find optimal radiation doses, in particular, for areas of regional metastasis, to reduce the risks of damage to surrounding organs and healthy tissues. A parallel search for optimal combinations of cytostatics and modes of injection leads to increase in survival rates for cervical cancer patients. Unfortunately, in Ukraine, the opposite trend is currently observed: amid active warfare, delayed medical consultation, and the forced intensification of treatment processes, the incidence of reproductive organ tumors in women has sharply increased, particularly among young women under 30, which makes the need to improve methods to combat this disease even more pressing. One possible strategy for acquiring new knowledge could be analyzing already catamnestic data on the course and outcomes of the disease using more advanced mathematical methods, including hidden knowledge discovery technology (Data Mining) and mathematical statistics. Рurpose – identify risk factors for long-term oncological outcomes, immediate radiation complications, and distant somatic complications, as well as methods for their prevention and mitigation, in order to improve individualized patient management programs for locally advanced cervical cancer. Materials and methods. The analyzed sample was based on follow-up data from medical histories of patients with locally advanced cervical cancer treated at the State Organization «Grigoriev Institute for Medical Radiology and Oncology of the National Academy of Medical Sciences of Ukraine» from 1998 to 2021. Selection criteria included medical histories with a follow-up duration of more than one year or documentation of disease manifestation within the initial (up to one year) period from the start of treatment. Complete observations included fatal outcomes, recurrences, and metastasis development. The selected medical histories were entered into an electronic database created according to an infological model developed at the start of the study. For mathematical analysis of the database content, the WizWhy package in the Data Mining category and nonparametric statistical methods (STATISTICA package) were used, including the Mann–Whitney test (MWT) and Pearsonʼs chi-square test (PCT). Descriptive statistics were provided as either the median or Me (LQ; UQ), where Me is the median, LQ is the lower quartile, and UQ is the upper quartile.In terms of the level of evidence, the study is a retrospective case-control study. Results. It was established that the risk factors for the appearance of cancer-specific long-term consequences of treatment in the future are the localization of the infiltrate, the characteristics of the cervical volume, the level of tumor specificity of the SCC marker, the level of platelets at the beginning of treatment and the dynamics of their decrease. Early radiation complications of treatment were analyzed and prognostic factors for the appearance of these complications were found, somatic disorders that appeared in the long term after the treatment were analyzed. Conclusions. The application of Data Mining technology and methods of mathematical statistics on the digitized array of catamnesis data of patients with cervical cancer made it possible to identify a number of non-trivial dependencies that are very valuable for preventing the development of remote cancer effects and improving treatment algorithms.
- 3 December 2024
- Published by Institute for Medical Radiology and Oncology of NAMS of Ukraine in Український радіологічний та онкологічний журнал
- Vol. 32 (4) , 478-490
Open AccessDetermination of risk factors for the occurrence of recurrences, metastases, and somatic complications after treatment of locally advanced cervical cancer using modern information technologies
Background. According to current data, the average incidence rate of cervical cancer is 9.0 cases per 100,000 people in developed countries and 17.8 cases per 100,000 people in developing countries. At the same time, the percentage of advanced stages (III–IV) of the disease remains high. Continuous improvement of radiation therapy methods has made it possible to find optimal radiation doses, in particular, for areas of regional metastasis, to reduce the risks of damage to surrounding organs and healthy tissues. A parallel search for optimal combinations of cytostatics and modes of injection leads to increase in survival rates for cervical cancer patients. Unfortunately, in Ukraine, the opposite trend is currently observed: amid active warfare, delayed medical consultation, and the forced intensification of treatment processes, the incidence of reproductive organ tumors in women has sharply increased, particularly among young women under 30, which makes the need to improve methods to combat this disease even more pressing. One possible strategy for acquiring new knowledge could be analyzing already catamnestic data on the course and outcomes of the disease using more advanced mathematical methods, including hidden knowledge discovery technology (Data Mining) and mathematical statistics. Рurpose – identify risk factors for long-term oncological outcomes, immediate radiation complications, and distant somatic complications, as well as methods for their prevention and mitigation, in order to improve individualized patient management programs for locally advanced cervical cancer. Materials and methods. The analyzed sample was based on follow-up data from medical histories of patients with locally advanced cervical cancer treated at the State Organization «Grigoriev Institute for Medical Radiology and Oncology of the National Academy of Medical Sciences of Ukraine» from 1998 to 2021. Selection criteria included medical histories with a follow-up duration of more than one year or documentation of disease manifestation within the initial (up to one year) period from the start of treatment. Complete observations included fatal outcomes, recurrences, and metastasis development. The selected medical histories were entered into an electronic database created according to an infological model developed at the start of the study. For mathematical analysis of the database content, the WizWhy package in the Data Mining category and nonparametric statistical methods (STATISTICA package) were used, including the Mann–Whitney test (MWT) and Pearsonʼs chi-square test (PCT). Descriptive statistics were provided as either the median or Me (LQ; UQ), where Me is the median, LQ is the lower quartile, and UQ is the upper quartile.In terms of the level of evidence, the study is a retrospective case-control study. Results. It was established that the risk factors for the appearance of cancer-specific long-term consequences of treatment in the future are the localization of the infiltrate, the characteristics of the cervical volume, the level of tumor specificity of the SCC marker, the level of platelets at the beginning of treatment and the dynamics of their decrease. Early radiation complications of treatment were analyzed and prognostic factors for the appearance of these complications were found, somatic disorders that appeared in the long term after the treatment were analyzed. Conclusions. The application of Data Mining technology and methods of mathematical statistics on the digitized array of catamnesis data of patients with cervical cancer made it possible to identify a number of non-trivial dependencies that are very valuable for preventing the development of remote cancer effects and improving treatment algorithms.
- Open Access
- 22 March 2024
- Published by Institute for Medical Radiology and Oncology of NAMS of Ukraine in Український радіологічний та онкологічний журнал
- Vol. 32 (1) , 44-55
Risk factors for local and distant metastasis and survival characteristics of patients with locally advanced cervical cancer, revealed on the basis of analysis of historical data for the period 1998–2021
Background. Cervical cancer is the second most common female malignant tumor in the world, which seriously threatens women’s health. The prevalence of cervical cancer in developed countries is 9 cases per 100 thousand people and almost twice as much (about 18 cases per 100 thousand female population) in developing countries. The survival rate of patients depends on the stage of the disease, and if detected late, it is critically low – 5–6% over a 5-year period. After clarifying the etiology of the disease as a persistent infection of the human papilloma virus, the processes of creating and implementing a comprehensive system of prevention and combating the disease were significantly accelerated. In 2018, WHO called for the elimination of cervical cancer worldwide, and more than 70 countries and international academic societies took immediate positive action to join this process. In 2020, WHO published a global strategy to combat cervical cancer as a pressing public health problem and put forward a list of the main areas of work for the prevention and control of cervical cancer in the future, which was supported by 194 countries of the world. Radiation therapy in combination with cisplatin-based chemotherapy is the standard of care for locally advanced cervical cancer. A possible way to improve the results of treatment is the search for risk factors for a negative prognosis and the appearance of remote oncological consequences (OC). Purpose. Determine the factors and time characteristics of the risk of local and distant metastasis in patients with locally advanced cervical cancer with radical conservative treatment. Materials and Methods. The basis for the work was the catamnetic data of the medical histories of patients with locally advanced cervical cancer who were treated at the State Organization «Grigoriev Institute for Medical Radiology and Oncology of the National Academy of Medical Sciences of Ukraine» in 1998–2021, the duration of observation of which was more than 1 year or the disease manifest was recorded at the initial stage (up to 1 year) from the start of treatment. Complete, uncensored observations were considered lethal consequences and the occurrence of relapses and metastases. The database for conducting the research was created in accordance with the informational model developed at the beginning of the research [1]. The WizWhy package of the Data Mining category and non-parametric statistics methods of the «STATISTICA» package (Mann–Whitney test, Pearson’s chi-square test) were used for information processing. Data by text are presented either as median or as Me (LQ;UQ), where Me is the median, LQ is the lower quartile, and UQ is the upper quartile. Patient survival was calculated using the Kaplan–Meier method. The proposed results are a continuation of the research results presented in [2]. The study belongs to the category of retrospective case-control studies. Results. The possibility of using indicators of cervical volume, platelet level, and their relative dynamics as prognostic factors for the appearance of remote oncological consequences of treatment of cervical cancer is shown, and a number of optimal parameters of radiation therapy to prevent their appearance are determined. Conclusions. The methods of mathematical statistics and intellectual data analysis (Data Mining) are a powerful tool for obtaining new non-obvious knowledge from arrays of «used» medical data, provided they are properly formalized and structured.
- 22 March 2024
- Published by Institute for Medical Radiology and Oncology of NAMS of Ukraine in Український радіологічний та онкологічний журнал
- Vol. 32 (1) , 44-55
Open AccessRisk factors for local and distant metastasis and survival characteristics of patients with locally advanced cervical cancer, revealed on the basis of analysis of historical data for the period 1998–2021
Background. Cervical cancer is the second most common female malignant tumor in the world, which seriously threatens women’s health. The prevalence of cervical cancer in developed countries is 9 cases per 100 thousand people and almost twice as much (about 18 cases per 100 thousand female population) in developing countries. The survival rate of patients depends on the stage of the disease, and if detected late, it is critically low – 5–6% over a 5-year period. After clarifying the etiology of the disease as a persistent infection of the human papilloma virus, the processes of creating and implementing a comprehensive system of prevention and combating the disease were significantly accelerated. In 2018, WHO called for the elimination of cervical cancer worldwide, and more than 70 countries and international academic societies took immediate positive action to join this process. In 2020, WHO published a global strategy to combat cervical cancer as a pressing public health problem and put forward a list of the main areas of work for the prevention and control of cervical cancer in the future, which was supported by 194 countries of the world. Radiation therapy in combination with cisplatin-based chemotherapy is the standard of care for locally advanced cervical cancer. A possible way to improve the results of treatment is the search for risk factors for a negative prognosis and the appearance of remote oncological consequences (OC). Purpose. Determine the factors and time characteristics of the risk of local and distant metastasis in patients with locally advanced cervical cancer with radical conservative treatment. Materials and Methods. The basis for the work was the catamnetic data of the medical histories of patients with locally advanced cervical cancer who were treated at the State Organization «Grigoriev Institute for Medical Radiology and Oncology of the National Academy of Medical Sciences of Ukraine» in 1998–2021, the duration of observation of which was more than 1 year or the disease manifest was recorded at the initial stage (up to 1 year) from the start of treatment. Complete, uncensored observations were considered lethal consequences and the occurrence of relapses and metastases. The database for conducting the research was created in accordance with the informational model developed at the beginning of the research [1]. The WizWhy package of the Data Mining category and non-parametric statistics methods of the «STATISTICA» package (Mann–Whitney test, Pearson’s chi-square test) were used for information processing. Data by text are presented either as median or as Me (LQ;UQ), where Me is the median, LQ is the lower quartile, and UQ is the upper quartile. Patient survival was calculated using the Kaplan–Meier method. The proposed results are a continuation of the research results presented in [2]. The study belongs to the category of retrospective case-control studies. Results. The possibility of using indicators of cervical volume, platelet level, and their relative dynamics as prognostic factors for the appearance of remote oncological consequences of treatment of cervical cancer is shown, and a number of optimal parameters of radiation therapy to prevent their appearance are determined. Conclusions. The methods of mathematical statistics and intellectual data analysis (Data Mining) are a powerful tool for obtaining new non-obvious knowledge from arrays of «used» medical data, provided they are properly formalized and structured.
- Open Access
- 15 June 2023
- Published by Institute for Medical Radiology and Oncology of NAMS of Ukraine in Український радіологічний та онкологічний журнал
- Vol. 31 (2) , 175-189
Risk factors of local recurrence and distant metastasis and manifestations of toxicity during chemoradiation treatment of cervical cancer patients
Relevance. Cervical cancer remains one of the most common malignancies in women worldwide, despite declining mortality rates due to large-scale screening programs and increased use of the human papillomavirus vaccine in Western countries. Although chemoradiotherapy has been recognized as the standard therapy for patients with locally advanced carcinoma, one-third of patients experience recurrence, and the effect of its treatment is far from satisfactory. In addition, factors affecting prognosis for patients with cervical cancer remain controversial. In connection with the above, research devoted to the analysis of the long-term clinical consequences of cervical cancer treatment and the search for prognostic factors remains extremely relevant. The purpose of the work is to determine the risk factors of local and distant metastasis and manifestations of toxicity during chemoradiation treatment of cervical cancer patients. Materials and methods. Paper case histories of non-operated patients with locally disseminated сervical cancer (stages 2B–4А) who underwent special treatment in the clinic of the institute in the period 1999–2020 were selected from the archive of the State Organization «Grigoriev Institute for Medical Radiology and Oncology of the National Academy of Medical Sciences of Ukraine» for inclusion in the electronic database. The selection criterion was either a follow-up period of more than 1 year, or a tracked recurrence of the disease within a period of up to 1 year. The end of observation was considered either the death of the patient, or the appearance of oncological consequences of the disease, or withdrawal from observation for unknown reasons (censored observations). The WizWhy package of the Data Mining category was used to conduct the research and propose hypotheses, followed by hypothesis testing by non-parametric statistical methods using the STATISTICA and SPSS general-purpose software package. Non-parametric methods were used – Pearson’s chi-squared test and the Mann–Whitney U-test. Results and discussion. A number of parameters and factors that have predictive properties regarding the risk of the appearance of oncological consequences of treatment in the future have been identified. The main immediate and remote consequences of chemoradiation treatment of patients and remote somatic consequences of combined treatment were analyzed. Conclusions. Catamnetic data of «processed» case histories, provided they are processed by appropriate mathematical methods, are a potential source for obtaining new non-obvious knowledge. In particular, the correct analytical approach to the processing of formalized medical history data made it possible to find a number of risk factors for local and distant metastasis and manifestations of toxicity during chemoradiation treatment of non-operated patients with locally disseminated cervical cancer, which creates the basis for the development of proposals for adjusting antitumor therapy and individualized patient support. Актуальність. Рак шийки матки (РШМ) залишається одним із найпоширеніших злоякісних новоутворень у жінок у всьому світі, незважаючи на зниження смертності через широкомасштабні програми скринінгу та більш широке використання вакцини проти вірусу папіломи людини в західних країнах. Хоча хіміопроменева терапія була визнана стандартною терапією для пацієнтів із місцево-поширеною карциномою, у однієї третини хворих спостерігається рецидив, а ефект від його лікування є далеким від задовільного. Крім того, фактори, що впливають на прогноз для хворих на рак шийки матки, залишаються дискусійними. У зв’язку з вищевикладеним, дослідження, присвячені аналізу віддалених клінічних наслідків лікування раку шийки матки та пошук прогностичних факторів, залишаються надзвичайно актуальними. Мета роботи. Визначити фактори ризику локального і віддаленого метастазування та проявів токсичності при хіміопроменевому лікуванні хворих на рак шийки матки. Матеріали та методи. З архіву Державної установи «Інститут медичної радіології та онкології ім. С.П. Григор’єва Національної академії медичних наук України» для внесення в електронну базу даних відбиралися паперові історії хвороби неоперованих пацієнтів з місцево-розповсюдженим РШМ (стадії 2B–4А), які проходили спеціальне лікування в клініці інституту в період з 1999 по 2020 рр. Критерієм відбору були або період спостереження більший за 1 рік, або відстежений рецидив захворювання в період до 1 року. Завершенням спостереження вважали або смерть пацієнта, або появу онкологічних наслідків захворювання, або вибуття із спостереження з невідомих причин...
- 15 June 2023
- Published by Institute for Medical Radiology and Oncology of NAMS of Ukraine in Український радіологічний та онкологічний журнал
- Vol. 31 (2) , 175-189
Open AccessRisk factors of local recurrence and distant metastasis and manifestations of toxicity during chemoradiation treatment of cervical cancer patients
Relevance. Cervical cancer remains one of the most common malignancies in women worldwide, despite declining mortality rates due to large-scale screening programs and increased use of the human papillomavirus vaccine in Western countries. Although chemoradiotherapy has been recognized as the standard therapy for patients with locally advanced carcinoma, one-third of patients experience recurrence, and the effect of its treatment is far from satisfactory. In addition, factors affecting prognosis for patients with cervical cancer remain controversial. In connection with the above, research devoted to the analysis of the long-term clinical consequences of cervical cancer treatment and the search for prognostic factors remains extremely relevant. The purpose of the work is to determine the risk factors of local and distant metastasis and manifestations of toxicity during chemoradiation treatment of cervical cancer patients. Materials and methods. Paper case histories of non-operated patients with locally disseminated сervical cancer (stages 2B–4А) who underwent special treatment in the clinic of the institute in the period 1999–2020 were selected from the archive of the State Organization «Grigoriev Institute for Medical Radiology and Oncology of the National Academy of Medical Sciences of Ukraine» for inclusion in the electronic database. The selection criterion was either a follow-up period of more than 1 year, or a tracked recurrence of the disease within a period of up to 1 year. The end of observation was considered either the death of the patient, or the appearance of oncological consequences of the disease, or withdrawal from observation for unknown reasons (censored observations). The WizWhy package of the Data Mining category was used to conduct the research and propose hypotheses, followed by hypothesis testing by non-parametric statistical methods using the STATISTICA and SPSS general-purpose software package. Non-parametric methods were used – Pearson’s chi-squared test and the Mann–Whitney U-test. Results and discussion. A number of parameters and factors that have predictive properties regarding the risk of the appearance of oncological consequences of treatment in the future have been identified. The main immediate and remote consequences of chemoradiation treatment of patients and remote somatic consequences of combined treatment were analyzed. Conclusions. Catamnetic data of «processed» case histories, provided they are processed by appropriate mathematical methods, are a potential source for obtaining new non-obvious knowledge. In particular, the correct analytical approach to the processing of formalized medical history data made it possible to find a number of risk factors for local and distant metastasis and manifestations of toxicity during chemoradiation treatment of non-operated patients with locally disseminated cervical cancer, which creates the basis for the development of proposals for adjusting antitumor therapy and individualized patient support. Актуальність. Рак шийки матки (РШМ) залишається одним із найпоширеніших злоякісних новоутворень у жінок у всьому світі, незважаючи на зниження смертності через широкомасштабні програми скринінгу та більш широке використання вакцини проти вірусу папіломи людини в західних країнах. Хоча хіміопроменева терапія була визнана стандартною терапією для пацієнтів із місцево-поширеною карциномою, у однієї третини хворих спостерігається рецидив, а ефект від його лікування є далеким від задовільного. Крім того, фактори, що впливають на прогноз для хворих на рак шийки матки, залишаються дискусійними. У зв’язку з вищевикладеним, дослідження, присвячені аналізу віддалених клінічних наслідків лікування раку шийки матки та пошук прогностичних факторів, залишаються надзвичайно актуальними. Мета роботи. Визначити фактори ризику локального і віддаленого метастазування та проявів токсичності при хіміопроменевому лікуванні хворих на рак шийки матки. Матеріали та методи. З архіву Державної установи «Інститут медичної радіології та онкології ім. С.П. Григор’єва Національної академії медичних наук України» для внесення в електронну базу даних відбиралися паперові історії хвороби неоперованих пацієнтів з місцево-розповсюдженим РШМ (стадії 2B–4А), які проходили спеціальне лікування в клініці інституту в період з 1999 по 2020 рр. Критерієм відбору були або період спостереження більший за 1 рік, або відстежений рецидив захворювання в період до 1 року. Завершенням спостереження вважали або смерть пацієнта, або появу онкологічних наслідків захворювання, або вибуття із спостереження з невідомих причин...
- Open Access
- 30 March 2023
- Published by Institute for Medical Radiology and Oncology of NAMS of Ukraine in Український радіологічний та онкологічний журнал
- Vol. 31 (1) , 83-92
An infographic model of a database for conducting an analytical study of the long-term consequences of cervical cancer treatment
Relevance. The development of ideas of critical attitude to medical information led to the concepts of evidence-based medicine (EM) in the late 1980s. The main postulates of EM are following: – every doctor’s decision must be based on scientific data; – the weight of each fact is greater, the stricter the method of scientific research in the course of which it was obtained. Correct planning of the research design and qualified statistical analysis are the most important for obtaining reliable, scientifically based results. The application of modern information technologies to arrays of catamnetic data of patients with cervical cancer (CRC) provides an opportunity to conduct a scientific study on the detection of the dependence of the appearance of oncological consequences of CRC treatment (metastases, relapses, secondary cancers) and manifestations of radiation toxicity on the clinical and biological characteristics of the patient and the features of the performed chemoradiation treatment. A necessary component of the success of such research is strict adherence to the principles of evidence-based medicine at all stages, in particular research planning. The main task at this stage is to determine the informative constitutional and biological, biometric, and social characteristics of the patient, parameters of treatment and the development of the disease in order to create a relevant informational model of the research database. The purpose of the work is to create an infological model of the catamnetic database of patients with CRC in order to determine the risk factors of local and distant metastasis and radiation toxicity during radical chemoradiation treatment of patients with CRC. Materials and methods: scientific literature with a level of evidence of primary data not lower than 2+, analysis of own experience, specialized analytical system «Database of patients». Results and discussion. An infological model of the database of catamnetic data of patients with CRC has been created, which provides the most complete representation of the subject area, contains all the entities and their attributes necessary for implementation. It is shown which parameters, factors and features of the disease should be taken into account when creating a database to obtain informationally significant results based on the accumulated data. Conclusions. The relevant informational model of the research database created in accordance with the approaches of evidence-based medicine is a necessary component for obtaining scientifically based results based on the catamnetic data of patients with CRC. Актуальність. Розвиток ідей критичної оцінки медичної інформації привів до виникнення наприкінці 80-х років XX століття концепції доказової медицини (ДМ). Основними постулатами ДМ є такі: – кожне рішення лікаря має ґрунтуватися на наукових даних; – вага кожного факту тим більше, чим суворіше методика наукового дослідження, у процесі якого він отриманий. Правильне планування структури дослідження і грамотний статистичний аналіз, з погляду ДМ, є найбільш важливими для отримання надійних, науково обґрунтованих результатів. Застосування сучасних інформаційних технологій до масивів катамнестичних даних хворих на рак шийки матки (РШМ) надає можливість провести наукове дослідження щодо виявлення залежності появи онкологічних наслідків лікування РШМ (метастази, рецидиви, вторинні раки) і проявів променевої токсичності від клініко-біологічних характеристик пацієнта та особливостей проведеного хіміопроменевого лікування. Необхідною складовою успіху такого дослідження є неухильне дотримання принципів доказової медицини на всіх етапах його проведення, зокрема планування дослідження. Стосовно проблеми, що вирішується, основним завданням планування є визначення інформативних конституційнобіологічних біометричних, соціальних характеристик пацієнта, параметрів лікування та перебігу захворювання для створення релевантної інфологічної моделі бази даних дослідження. Мета роботи – створити інфологічну модель бази катамнестичних даних для визначення факторів ризику локального і віддаленого метастазування й променевої токсичності при радикальному хіміопроменевому лікуванні хворих на РШМ. Матеріали та методи. Літературні джерела за рівнем доведеності первинних даних не нижче за 2+, аналіз власного досвіду, спеціалізована аналітична система «База даних хворих». Результати та їх обговорення. Створено...
- 30 March 2023
- Published by Institute for Medical Radiology and Oncology of NAMS of Ukraine in Український радіологічний та онкологічний журнал
- Vol. 31 (1) , 83-92
Open AccessAn infographic model of a database for conducting an analytical study of the long-term consequences of cervical cancer treatment
Relevance. The development of ideas of critical attitude to medical information led to the concepts of evidence-based medicine (EM) in the late 1980s. The main postulates of EM are following: – every doctor’s decision must be based on scientific data; – the weight of each fact is greater, the stricter the method of scientific research in the course of which it was obtained. Correct planning of the research design and qualified statistical analysis are the most important for obtaining reliable, scientifically based results. The application of modern information technologies to arrays of catamnetic data of patients with cervical cancer (CRC) provides an opportunity to conduct a scientific study on the detection of the dependence of the appearance of oncological consequences of CRC treatment (metastases, relapses, secondary cancers) and manifestations of radiation toxicity on the clinical and biological characteristics of the patient and the features of the performed chemoradiation treatment. A necessary component of the success of such research is strict adherence to the principles of evidence-based medicine at all stages, in particular research planning. The main task at this stage is to determine the informative constitutional and biological, biometric, and social characteristics of the patient, parameters of treatment and the development of the disease in order to create a relevant informational model of the research database. The purpose of the work is to create an infological model of the catamnetic database of patients with CRC in order to determine the risk factors of local and distant metastasis and radiation toxicity during radical chemoradiation treatment of patients with CRC. Materials and methods: scientific literature with a level of evidence of primary data not lower than 2+, analysis of own experience, specialized analytical system «Database of patients». Results and discussion. An infological model of the database of catamnetic data of patients with CRC has been created, which provides the most complete representation of the subject area, contains all the entities and their attributes necessary for implementation. It is shown which parameters, factors and features of the disease should be taken into account when creating a database to obtain informationally significant results based on the accumulated data. Conclusions. The relevant informational model of the research database created in accordance with the approaches of evidence-based medicine is a necessary component for obtaining scientifically based results based on the catamnetic data of patients with CRC. Актуальність. Розвиток ідей критичної оцінки медичної інформації привів до виникнення наприкінці 80-х років XX століття концепції доказової медицини (ДМ). Основними постулатами ДМ є такі: – кожне рішення лікаря має ґрунтуватися на наукових даних; – вага кожного факту тим більше, чим суворіше методика наукового дослідження, у процесі якого він отриманий. Правильне планування структури дослідження і грамотний статистичний аналіз, з погляду ДМ, є найбільш важливими для отримання надійних, науково обґрунтованих результатів. Застосування сучасних інформаційних технологій до масивів катамнестичних даних хворих на рак шийки матки (РШМ) надає можливість провести наукове дослідження щодо виявлення залежності появи онкологічних наслідків лікування РШМ (метастази, рецидиви, вторинні раки) і проявів променевої токсичності від клініко-біологічних характеристик пацієнта та особливостей проведеного хіміопроменевого лікування. Необхідною складовою успіху такого дослідження є неухильне дотримання принципів доказової медицини на всіх етапах його проведення, зокрема планування дослідження. Стосовно проблеми, що вирішується, основним завданням планування є визначення інформативних конституційнобіологічних біометричних, соціальних характеристик пацієнта, параметрів лікування та перебігу захворювання для створення релевантної інфологічної моделі бази даних дослідження. Мета роботи – створити інфологічну модель бази катамнестичних даних для визначення факторів ризику локального і віддаленого метастазування й променевої токсичності при радикальному хіміопроменевому лікуванні хворих на РШМ. Матеріали та методи. Літературні джерела за рівнем доведеності первинних даних не нижче за 2+, аналіз власного досвіду, спеціалізована аналітична система «База даних хворих». Результати та їх обговорення. Створено...
- Open Access
- 12 December 2022
- Published by Institute for Medical Radiology and Oncology of NAMS of Ukraine in Український радіологічний та онкологічний журнал
- Vol. 30 (3) , 22-32
Use of 3D planning of HDR brachytherapy in patients with cervical cancer
Background. Combined radiation therapy is the «gold standard» for the treatment of stages IIB-IVA of cervical cancer (cervical cancer). Given the data of statistical indicators of cervical cancer, the study of new approaches to treatment and implementation in clinical practice of modern technologies of radiation therapy of widespread cervical cancer is an extremely important area. Purpose – evaluate the benefits of using CT topometric preparation in planning brachytherapy for cervical cancer. Materials and Methods. 3D planning of brachytherapy of 24 patients with locally advanced cervical cancer (FIGO IIIB stage), who underwent a radical program of combined radiation therapy (remote radiation therapy with chemical modification with cisplatin followed by HDR-brachytherapy (High dose rate brachytherapy)). Results. The paper presents the results of the analysis of differences in brachytherapy planning according to orthogonal images and CT images. The analysis of the influence of the constitutional features of patients revealed that there are differences in the topographic anatomy of the pelvis depending on the surface area of the body. In patients with a body surface area of up to 1,65 m2 , a more intimate fit of the intestine to the target volume of irradiation was noted. No similar planning difficulties were found in patients with a body surface area above 1,65 m2 . Conclusions. The use of 3D images in the planning of intracavitary irradiation in patients with cervical cancer provides precision brachytherapy by simultaneously visualizing the irradiated volumes and spatial relationships of the anatomical structures of the pelvis, the introduced endostats and the corresponding volumetric dose distributions. Актуальність. Проведення поєднано-променевої терапії є «золотим стандартом» лікування IIВ-IVA стадій раку шийки матки (РШМ). Враховуючи дані статистичних показників захворюваності на РШМ, вивчення нових підходів до лікування та впровадження у клінічну практику сучасних технологій променевої терапії місцеворозповсюдженого РШМ є вкрай актуальним напрямком. Мета роботи. Оцінити переваги використання КТ-топометричної підготовки при плануванні брахітерапії раку шийки матки. Матеріали та методи. Проведено 3D-планування брахітерапії 24 пацієнток з місцево-розповсюдженим раком шийки матки (FIGO IIIB стадія), яким була проведена радикальна програма поєднано-променевого лікування (дистанційна променева терапія з хіміомодифікацією цисплатином з подальшою брахітерапією високої потужності дози (HDR-брахітерапія)). Результати та їх обговорення. В роботі представлено результати аналізу відмінностей планування брахітерапії за ортогональними знімками та КТ зображеннями. При аналізі впливу конституціональних особливостей пацієнток виявлено, що є відмінності у топографічній анатомії малого таза залежно від площі поверхні тіла. У пацієнток з площею поверхні тіла до 1,65 м2 відзначено більш інтимне прилягання кишечника до таргетного об’єму опромінення. У пацієнток з площею поверхні тіла вище 1,65 м2 подібних труднощів з плануванням не визначалось. Висновки. Використання 3D-зображень для планування внутрішньо-порожнинного опромінення у хворих на рак шийки матки забезпечує прецизіозність брахітерапії шляхом одночасної візуалізації опромінених обсягів та просторових співвідношень анатомічних структур малого таза, введених ендостатів та відповідних об’ємних дозних розподілів.
- 12 December 2022
- Published by Institute for Medical Radiology and Oncology of NAMS of Ukraine in Український радіологічний та онкологічний журнал
- Vol. 30 (3) , 22-32
Open AccessUse of 3D planning of HDR brachytherapy in patients with cervical cancer
Background. Combined radiation therapy is the «gold standard» for the treatment of stages IIB-IVA of cervical cancer (cervical cancer). Given the data of statistical indicators of cervical cancer, the study of new approaches to treatment and implementation in clinical practice of modern technologies of radiation therapy of widespread cervical cancer is an extremely important area. Purpose – evaluate the benefits of using CT topometric preparation in planning brachytherapy for cervical cancer. Materials and Methods. 3D planning of brachytherapy of 24 patients with locally advanced cervical cancer (FIGO IIIB stage), who underwent a radical program of combined radiation therapy (remote radiation therapy with chemical modification with cisplatin followed by HDR-brachytherapy (High dose rate brachytherapy)). Results. The paper presents the results of the analysis of differences in brachytherapy planning according to orthogonal images and CT images. The analysis of the influence of the constitutional features of patients revealed that there are differences in the topographic anatomy of the pelvis depending on the surface area of the body. In patients with a body surface area of up to 1,65 m2 , a more intimate fit of the intestine to the target volume of irradiation was noted. No similar planning difficulties were found in patients with a body surface area above 1,65 m2 . Conclusions. The use of 3D images in the planning of intracavitary irradiation in patients with cervical cancer provides precision brachytherapy by simultaneously visualizing the irradiated volumes and spatial relationships of the anatomical structures of the pelvis, the introduced endostats and the corresponding volumetric dose distributions. Актуальність. Проведення поєднано-променевої терапії є «золотим стандартом» лікування IIВ-IVA стадій раку шийки матки (РШМ). Враховуючи дані статистичних показників захворюваності на РШМ, вивчення нових підходів до лікування та впровадження у клінічну практику сучасних технологій променевої терапії місцеворозповсюдженого РШМ є вкрай актуальним напрямком. Мета роботи. Оцінити переваги використання КТ-топометричної підготовки при плануванні брахітерапії раку шийки матки. Матеріали та методи. Проведено 3D-планування брахітерапії 24 пацієнток з місцево-розповсюдженим раком шийки матки (FIGO IIIB стадія), яким була проведена радикальна програма поєднано-променевого лікування (дистанційна променева терапія з хіміомодифікацією цисплатином з подальшою брахітерапією високої потужності дози (HDR-брахітерапія)). Результати та їх обговорення. В роботі представлено результати аналізу відмінностей планування брахітерапії за ортогональними знімками та КТ зображеннями. При аналізі впливу конституціональних особливостей пацієнток виявлено, що є відмінності у топографічній анатомії малого таза залежно від площі поверхні тіла. У пацієнток з площею поверхні тіла до 1,65 м2 відзначено більш інтимне прилягання кишечника до таргетного об’єму опромінення. У пацієнток з площею поверхні тіла вище 1,65 м2 подібних труднощів з плануванням не визначалось. Висновки. Використання 3D-зображень для планування внутрішньо-порожнинного опромінення у хворих на рак шийки матки забезпечує прецизіозність брахітерапії шляхом одночасної візуалізації опромінених обсягів та просторових співвідношень анатомічних структур малого таза, введених ендостатів та відповідних об’ємних дозних розподілів.
- Open Access
- 12 December 2022
- Published by Institute for Medical Radiology and Oncology of NAMS of Ukraine in Український радіологічний та онкологічний журнал
- Vol. 30 (3) , 65-78
Treatment strategy and clinical characteristics of patients with cervical cancer as prognostic parameters of survival
Background. Cervical cancer (CRC) ranks second in the world among all malignant neoplasms of the female genital organs. According to the WHO, more than 500000 new cases of CRC are detected annually in the world. In 2021, 3398 new cases of the disease were registered in Ukraine. Currently a number of factors that have a rather high individual prognostic significance influences the CRC development. Among these factors are those which are associated with an adverse outcome: heavy hereditary anamnesis, growth form of tumor and its localization, variant of spread, depth of invasion into the stroma, morphological structure, methods of treatment, etc. Over the last decade, there has been an unfavorable trend towards an increase in the number of young patients who have an advanced tumor process, which significantly restricts methods and reduces the chances of the successful treatment. Thereby, the high level of morbidity and mortality from CRC, especially among young patients, as well as the unsatisfactory results of 5-year survival after traditional methods of treatment, indicate that the cancer of this type is the prior problem in domestic oncology. Purpose. To make scientific analysis of modern treatment strategies and characteristics of CRC as prognostic survival parameters. Materials and methods. The literature review included available full-text publications, which were obtained as a result of an in-depth analysis of foreign and domestic scientific publications. Results. Authors gave analysis of modern domestic and foreign literature on the evaluation of the effectiveness of treatment of cervical cancer patients; namely, how treatment strategies, individual characteristics of patients and characteristics of the tumor affect the results of treatment and prognosis of patient survival. It is shown which parameters, factors and important nuances of the disease should be taken into account, which is decisive in choosing treatment tactics and preventing complications. Conclusions. Knowing and taking into account the prognostic parameters of the survival of cervical cancer patients is important for the assessment of treatment standards, as well as the development of personalized tactics for the treatment and monitoring of this disease.
- 12 December 2022
- Published by Institute for Medical Radiology and Oncology of NAMS of Ukraine in Український радіологічний та онкологічний журнал
- Vol. 30 (3) , 65-78
Open AccessTreatment strategy and clinical characteristics of patients with cervical cancer as prognostic parameters of survival
Background. Cervical cancer (CRC) ranks second in the world among all malignant neoplasms of the female genital organs. According to the WHO, more than 500000 new cases of CRC are detected annually in the world. In 2021, 3398 new cases of the disease were registered in Ukraine. Currently a number of factors that have a rather high individual prognostic significance influences the CRC development. Among these factors are those which are associated with an adverse outcome: heavy hereditary anamnesis, growth form of tumor and its localization, variant of spread, depth of invasion into the stroma, morphological structure, methods of treatment, etc. Over the last decade, there has been an unfavorable trend towards an increase in the number of young patients who have an advanced tumor process, which significantly restricts methods and reduces the chances of the successful treatment. Thereby, the high level of morbidity and mortality from CRC, especially among young patients, as well as the unsatisfactory results of 5-year survival after traditional methods of treatment, indicate that the cancer of this type is the prior problem in domestic oncology. Purpose. To make scientific analysis of modern treatment strategies and characteristics of CRC as prognostic survival parameters. Materials and methods. The literature review included available full-text publications, which were obtained as a result of an in-depth analysis of foreign and domestic scientific publications. Results. Authors gave analysis of modern domestic and foreign literature on the evaluation of the effectiveness of treatment of cervical cancer patients; namely, how treatment strategies, individual characteristics of patients and characteristics of the tumor affect the results of treatment and prognosis of patient survival. It is shown which parameters, factors and important nuances of the disease should be taken into account, which is decisive in choosing treatment tactics and preventing complications. Conclusions. Knowing and taking into account the prognostic parameters of the survival of cervical cancer patients is important for the assessment of treatment standards, as well as the development of personalized tactics for the treatment and monitoring of this disease.
- Open Access
- 17 December 2020
- Published by Institute for Medical Radiology and Oncology of NAMS of Ukraine in Український радіологічний та онкологічний журнал
- Vol. 28 (4) , 364-373
Risk of recurrence of malignant tumors of the ovaries and levels of tumor markers НЕ-4 and СА-125
Background. Timely diagnosis of recurrence of malignant tumors of the ovaries can improve treatment outcomes. Purpose – determine the feasibility of using the tumor marker HE-4 in case of recurrence of malignant ovarian tumors. Materials and methods. To analyze the levels of HE-4 and CA-125 in patients with recurrence of malignant ovarian tumors and determine the feasibility of using HE-4 at this stage of monitoring, 29 patients with known indicators of HE-4 and CA-125 at the time of recurrence and their baseline data were selected. Results and discussion. The paper presents the results of the study of the HE-4 and CA-125 tumor markers levels in 29 patients with a proven recurrence of malignant ovarian neoplasms depending on the timing of its appearance – up to 12 months (n = 9), 13–24 months (n = 11) and after 24 months (n = 9). The values of the tumor-associated HE-4 marker were decreased during the relapse compared to baseline expression levels. When analyzing of the HE-4 serum, their significant difference was revealed only in the event of relapse in the period of up to one year (1207.00 pmol/l) from recurrence rates in the periods of 13–24 and of over 24 months (567.00 and 655.50 pmol/l, respectively). Conclusions. Only the baseline expression of HE-4 is prognostically significant for determining the timing of recurrence of ovarian malignancies.
- 17 December 2020
- Published by Institute for Medical Radiology and Oncology of NAMS of Ukraine in Український радіологічний та онкологічний журнал
- Vol. 28 (4) , 364-373
Open AccessRisk of recurrence of malignant tumors of the ovaries and levels of tumor markers НЕ-4 and СА-125
Background. Timely diagnosis of recurrence of malignant tumors of the ovaries can improve treatment outcomes. Purpose – determine the feasibility of using the tumor marker HE-4 in case of recurrence of malignant ovarian tumors. Materials and methods. To analyze the levels of HE-4 and CA-125 in patients with recurrence of malignant ovarian tumors and determine the feasibility of using HE-4 at this stage of monitoring, 29 patients with known indicators of HE-4 and CA-125 at the time of recurrence and their baseline data were selected. Results and discussion. The paper presents the results of the study of the HE-4 and CA-125 tumor markers levels in 29 patients with a proven recurrence of malignant ovarian neoplasms depending on the timing of its appearance – up to 12 months (n = 9), 13–24 months (n = 11) and after 24 months (n = 9). The values of the tumor-associated HE-4 marker were decreased during the relapse compared to baseline expression levels. When analyzing of the HE-4 serum, their significant difference was revealed only in the event of relapse in the period of up to one year (1207.00 pmol/l) from recurrence rates in the periods of 13–24 and of over 24 months (567.00 and 655.50 pmol/l, respectively). Conclusions. Only the baseline expression of HE-4 is prognostically significant for determining the timing of recurrence of ovarian malignancies.